Genezen News & Resources

Keep up to date with the latest news at Genezen, and explore our expert content around molecular biology news and insights.

Scroll Down

Filter

By type

By service

Premium content

Genezen Enters Licensing Agreement with CSL…

February 21, 2024 – Genezen, a leading cell and gene therapy...

Read more

Bringing Therapies to Life with Multi-Vector…

Rapid expansion in biotechnology platforms and advancement in genetic editing technologies...

Read more

LVV Approaches to Pseudotyping and Plasmid…

As cell and gene therapies continue to provide unprecedented advancements in...

Read more

Genezen Announces the Appointment of Steven…

BOSTON, MA and FISHERS, IN. – March 13, 2023 – Genezen,...

Read more

Understanding the requirements of viral vector…

Analytical method development, qualification, and validation are an integral part of...

Read more

4 factors driving the trend towards…

The cell and gene therapy (C&GT) space is expanding rapidly. With...

Read more
Load more

Get insights like this directly to your inbox

Sign up to our newsletter

Our solutions

From Process Development, Testing, GMP Vector Manufacturing to Cell Manufacturing

Our team offers the guidance, expertise, technology, and manufacturing capacity to help bring your viral vector therapy to market with precision and speed.